CANCER TARGETED TECHNOLOGY - Key Persons
Carolyn J. Anderson, Ph.D. is a Professor of Radiology, Pharmacology & Chemical Biology and Bioengineering, and is the Director of the Molecular Imaging Laboratory at the University of Pittsburgh. Her research interests include the development and evaluation of novel radiometal-based radiopharmaceuticals for diagnostic imaging and targeted radiotherapy of cancer.
Job Titles:
- Chief Executive Officer
- Director
- Member of the Management Team
Dr. Beatrice Langton-Webster, CEO, and director, has over 30 years of experience in the biopharmaceutical industry with expertise in operational and executive management, licensing and strategic business development and preclinical & clinical cancer drug development. She helped bring to market: Betaseron® for multiple sclerosis, a HER-2 serum diagnostic kit for breast cancer and Fludara® for leukemia.
Job Titles:
- Director
- Founder
- Member of the Management Team
- Founder and Director of CTT
- Professor of Chemistry at Washington State University
Dr. Cliff Berkman, Founder and Director of CTT and Professor of Chemistry at Washington State University. He has over 25 years of experience in developing novel enzyme inhibitors for use in detecting tumors and sensitizing tumor cells to chemotherapeutics and targeted radionuclides. CTT's technology and lead drugs were designed and developed by Dr. Berkman.
Professor in Residence, Director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging (CMFI) at the University of California, San Francisco, and he is a Joint Faculty Scientist at the Lawrence Berkeley National Laboratory. He maintains an active radiotracer research program in addition to providing tracers for collaborative basic science and translational clinical research.
Job Titles:
- Director
- Founder
- Member of the Management Team
- Founder and Director / Management
Mr. John Dugan, Founder and Director has over 35 years of experience in the financial services industry and is a founder and general partner of OCA Ventures. Mr. Dugan has served as CEO and board member of Swiss Bank Corporation (SBC), North America; managing partner of OCA; CFO at Purcell, Graham & Co; VP at Bear Steams & Co; and CFO at Baker, Weeks & Co.
Job Titles:
- Assistant Clinical Professor of Medicine in the Department
Assistant Clinical Professor of Medicine in the Department of Medicine, Division of Hematology/Oncology at UCSF within the Genitourinary Oncology and Developmental Therapeutics programs. His clinical research is focused on developing novel therapeutic and imaging strategies for patients with advanced prostate cancer. He serves as Co-Investigator in the ongoing Prostate Cancer Foundation/SU2C-funded West Coast Dream Team prostate cancer consortium.
Job Titles:
- Assistant Professor of Clinical Radiology
Spencer Behr, MD
Assistant Professor of Clinical Radiology and the Director of the Fellowship for both the Abdominal Imaging subspecialty and for the Department of Radiology and Biomedical Imaging at the University of California, San Francisco.